国际皮肤性病学杂志    2010 36 (6): 325-327   ISSN: 2096-5540  CN: 32-1880/R  

普萘洛尔治疗婴儿重症血管瘤的疗效及不良反应
李丽北京1,马琳2
1. 首都医科大学附属北京儿童医院皮肤科
2. 北京市儿童医院皮肤科
收稿日期 2010-04-16  修回日期 2010-05-04  网络版发布日期 2010-11-10
参考文献  

1. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristicspredicting complications and treatment. Pediatrics 2006; 118: 882–887. 2 O. Enjolras, G.M, Breviere, G. Roger, M, Tovi, B, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch. Pediatr. 11 (February 2) (2004) 99–107. 3 Vincristine as a treatment for a large haemangioma threatening vital functions. Fawcett SL, Grant I, Hall PN, et al. Br J Plast Surg 2004; 57: 168-71. 4 Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. Ezekowitz RA, Mulliken JB, Folkman J. N Engl J Med 1992;326: 1456-63. 5 Treatment with interferon-alpha 2b in children with life-threatening hemangiomas. Jiminez-Hernandez E, Duenas-Gonzalez MT, Quintero-Curiel JL, et al. Dermatol Surg 2008; 34: 640-7. 6 C. Leaute-Labreze, E. Dumas de la Roque, T. Hubiche, et al. Propranolol for severe hemangiomas of infancy, N. Engl. J. Med. 358 (June 24) (2008) 2649–2651. 7 Lisa Buckmiller, MD; Umesh Dyamenahalli, MD; Gresham T. Richter, MD. Propranolol for Airway Hemangiomas: Case Report of Novel Treatment. Laryngoscope 119: October 2009, 2051-2054. 8 Alberto Marsciani, MD, Roberta Pericoli, MD, Rita Alaggio, MD, et al. Massive Response of Severe Infantile Hepatic Hemangioma to Propanolol. Pediatr Blood Cancer 2010;54:176. 9 Franc?oise Denoyelle, Nicolas Leboulanger, Odile Enjolras, et al. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. International Journal of Pediatric Otorhinolaryngology 73 (2009) 1168–1172. 10 T Theletsane, A Redfern, O Raynham, et al. Life-threatening infantile haemangioma: a dramatic response to propranolol. European Academy of Dermatology and Venereology 2009, 23: 1465-1466. 11 秦中平,刘学健,李克雷,等. 小剂量普萘洛尔口服治疗婴儿血管瘤的近期疗效与安全性评价.中华医学杂志 2009 89 (44). 12 Leslie P. Lawley, M.D.,Elaine Siegfried, M.D.,and Jane L. Todd, M.D. Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations. Pediatric Dermatology 2009; 26: 5610–5614. 13 Waseem Mousa, Kirsten Kues, Ellen Haas, et al. Successful treatment of a large hemangioma with propranolol. JDDG; 2009 Band 7: 1-3. 14 Micromedex R Healthcare Series [Internet database]. Greenwood Village, CO: Thomson Healthcare. Updated periodically. Available at: http://www.thomsonhc.com/hcs/ librarian/ND_T/HCS/ND_PR/Main/CS/68E386/DUPLI CATIONSHIELDSYNC/C313DB/ND_PG/PRIH/ND_ BHCS/SBK/3/ND_P/Main/PFPUI/D5129Kk2E4eFtP/PF ActionId/hcs.common.RetrieveDocumentCommon/DocId/6300-v/ContentSetId/30#secN101A6 (accessed on 5 January 2009). 15 Hoffman BB. Adrenoceptor antagonist drugs. In:Katzung BG, ed. Basic and clinical pharmacology, 10th ed. New York:McGraw-Hill, 2007:147–158. 16 Gottschling S, Schneider G, Meyer S, et al. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer 2006; 46: 239-42. 17 Burns CM, Rutherford MA, Boardman JP, et al. Patterns of cerebral injury and neuodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008; 122: 65-74.


通讯作者: 李丽北京